ES2054829T3 - Antibioticos del grupo mureidomicina, su preparacion y su empleo. - Google Patents

Antibioticos del grupo mureidomicina, su preparacion y su empleo.

Info

Publication number
ES2054829T3
ES2054829T3 ES88310822T ES88310822T ES2054829T3 ES 2054829 T3 ES2054829 T3 ES 2054829T3 ES 88310822 T ES88310822 T ES 88310822T ES 88310822 T ES88310822 T ES 88310822T ES 2054829 T3 ES2054829 T3 ES 2054829T3
Authority
ES
Spain
Prior art keywords
group
carbon atoms
mureidomycin
antibiotics
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88310822T
Other languages
English (en)
Inventor
Tatsuo C O Sankyo Com Haneishi
Masatoshi C O Sankyo Co Inukai
Keiko C O Sankyo Compa Shimizu
Fujio C O Sankyo Company Isono
Yoshiharu C O Sankyo C Sakaida
Takeshi C O Sankyo C Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2054829T3 publication Critical patent/ES2054829T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

NUEVOS ANTIBIOTICOS DEL GRUPO DE LA MUREIDOMICINA QUE TIENEN LA FORMULA(I), EN DONDE X ES H, UN GRUPO ALQUILO CON DE 1 A 10 C, UN GRUPO ALQUENILO CON DE 2 A 7 C, UN GRUPO ALQUINIO CON DE 3 A 7 C, UN GRUPO ARILO CON DE 6 A 10 C, UN GRUPO ARALQUILO QUE TIENE DICHOS GRUPOS ARILO O ARALQUILO SUSTITUIDO CON AL MENOS UN ATOMO HALOGENO Y/O ALMENOS UN GRUPO ALQUILO QUE TENGA DE 1 A 10 C. ESTE GRUPO DE COMPUESTOS Y SUS ESTERES Y SALES ACEPTABLES FARMACOLOGICAMENTE SON UITILES COMO ANTIBIOTICOS Y PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS.
ES88310822T 1987-11-20 1988-11-16 Antibioticos del grupo mureidomicina, su preparacion y su empleo. Expired - Lifetime ES2054829T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29335387 1987-11-20
JP29335287 1987-11-20

Publications (1)

Publication Number Publication Date
ES2054829T3 true ES2054829T3 (es) 1994-08-16

Family

ID=26559375

Family Applications (2)

Application Number Title Priority Date Filing Date
ES92202494T Expired - Lifetime ES2077345T3 (es) 1987-11-20 1988-11-16 Intermediarios del grupo mureidomicina, su preparacion y su uso.
ES88310822T Expired - Lifetime ES2054829T3 (es) 1987-11-20 1988-11-16 Antibioticos del grupo mureidomicina, su preparacion y su empleo.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES92202494T Expired - Lifetime ES2077345T3 (es) 1987-11-20 1988-11-16 Intermediarios del grupo mureidomicina, su preparacion y su uso.

Country Status (8)

Country Link
US (1) US5041423A (es)
EP (2) EP0517345B1 (es)
KR (2) KR0137779B1 (es)
AT (1) ATE125256T1 (es)
CA (1) CA1339595C (es)
DE (2) DE3854205T2 (es)
ES (2) ES2077345T3 (es)
HK (2) HK1003573A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487756A1 (en) * 1990-11-26 1992-06-03 Hoechst Aktiengesellschaft Antibiotics napsamycins A-D, process for their production and their use as pharmaceuticals
US6228842B1 (en) 1998-11-06 2001-05-08 Microcide Pharmaceuticals, Inc. Pacidamycins produced by Streptomyces coeruleorubidus
US6482921B1 (en) * 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
DE60116787T2 (de) * 2001-09-27 2006-08-24 Biocon Ltd., Hebbagodi Verfahren zur herstellung von pravastatin-natriumsalz mittels streptomyces flavidovirens dsm 14455
KR102302414B1 (ko) 2014-06-20 2021-09-16 주식회사 만도 임피던스 저감을 위한 피씨비와 섀시간의 그라운드 결합구조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
GB8421279D0 (en) * 1984-08-22 1984-09-26 Baldwin J E Antibiotics
IT1184164B (it) * 1985-03-19 1987-10-22 Eniricerche Spa Triptidi ad azione ipotensiva e procedimento per la loro sintesi
KR950013857B1 (ko) * 1986-05-20 1995-11-17 상꾜 가부시끼가이샤 신규 항생물질 무레이도마이신 a, b, c 및 d 그의 제조 방법 및 치료학적 용도

Also Published As

Publication number Publication date
DE3880092T2 (de) 1993-11-25
US5041423A (en) 1991-08-20
EP0317292A3 (en) 1990-07-25
CA1339595C (en) 1997-12-23
EP0317292B1 (en) 1993-04-07
HK1003573A1 (en) 1998-10-30
KR0137675B1 (ko) 1998-05-15
DE3854205D1 (de) 1995-08-24
KR0137779B1 (ko) 1998-05-15
DE3880092D1 (de) 1993-05-13
EP0517345B1 (en) 1995-07-19
HK1005736A1 (en) 1999-01-22
DE3854205T2 (de) 1996-04-04
ATE125256T1 (de) 1995-08-15
ES2077345T3 (es) 1995-11-16
EP0317292A2 (en) 1989-05-24
EP0517345A1 (en) 1992-12-09
KR890008130A (ko) 1989-07-08

Similar Documents

Publication Publication Date Title
DE3881246T2 (de) Durch Benzhydryl N-substituierte heterocyclische Derivate, ihre Herstellung und ihre Verwendung.
AU8682191A (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
KR910021406A (ko) 축합 티아졸 화합물, 그의 제조 방법 및 용도
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
ES8506731A1 (es) Un procedimiento para preparar derivados de cefalosporina
IE891900L (en) Substituted 3-aminosydnone imines, a process for their¹preparation and their use
PT99250A (pt) Processo para a preparacao de derivados de piperazina
SE7709646L (sv) Antibakteriella medel
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat
ES2026548T3 (es) Un procedimiento para preparar penemos.
FI943596A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten makrolidiyhdisteiden valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 317292

Country of ref document: ES